Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-28

Clinical Trial Update: Rosuvastatin Effect on Atherosclerotic Plaque Metabolism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of rosuvastatin on atherosclerotic plaque metabolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: University of Coimbra | Conditions: Cardiovascular Diseases, Atherosclerosis | Phase 4 | Status: COMPLETED